Ancora Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $864 | Hold |
35
| – | – | ﹤0.01% | 1748 |
|
|
2025
Q1 | $737 | Sell |
35
-36
| -51% | -$758 | ﹤0.01% | 1598 |
|
|
2024
Q4 | $1.67K | Sell |
71
-411
| -85% | -$9.68K | ﹤0.01% | 1560 |
|
|
2024
Q3 | $12.3K | Sell |
482
-10
| -2% | -$256 | ﹤0.01% | 1262 |
|
|
2024
Q2 | $11.6K | Buy |
492
+373
| +313% | +$8.76K | ﹤0.01% | 1239 |
|
|
2024
Q1 | $3.42K | Sell |
119
-8,686
| -99% | -$250K | ﹤0.01% | 1450 |
|
|
2023
Q4 | $289K | Sell |
8,805
-102
| -1% | -$3.35K | 0.01% | 585 |
|
|
2023
Q3 | $248K | Buy |
8,907
+31
| +0.3% | +$864 | 0.01% | 601 |
|
|
2023
Q2 | $303K | Sell |
8,876
-407
| -4% | -$13.9K | 0.01% | 551 |
|
|
2023
Q1 | $279K | Buy |
9,283
+39
| +0.4% | +$1.17K | 0.01% | 576 |
|
|
2022
Q4 | $261K | Buy |
9,244
+165
| +2% | +$4.66K | 0.01% | 600 |
|
|
2022
Q3 | $298K | Sell |
9,079
-198
| -2% | -$6.5K | 0.01% | 606 |
|
|
2022
Q2 | $292K | Buy |
9,277
+741
| +9% | +$23.3K | 0.01% | 637 |
|
|
2022
Q1 | $392K | Sell |
8,536
-3,869
| -31% | -$178K | 0.01% | 593 |
|
|
2021
Q4 | $760K | Sell |
12,405
-9,482
| -43% | -$581K | 0.02% | 442 |
|
|
2021
Q3 | $1.64M | Buy |
21,887
+40
| +0.2% | +$2.99K | 0.04% | 298 |
|
|
2021
Q2 | $2.02M | Buy |
21,847
+5,005
| +30% | +$463K | 0.05% | 270 |
|
|
2021
Q1 | $1.49M | Buy |
16,842
+7,873
| +88% | +$698K | 0.04% | 302 |
|
|
2020
Q4 | $836K | Buy |
8,969
+8,885
| +10,577% | +$828K | 0.03% | 381 |
|
|
2020
Q3 | $5K | Buy |
84
+59
| +236% | +$3.51K | ﹤0.01% | 1195 |
|
|
2020
Q2 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 1253 |
|